Tetsuya Taguchi

13.5k citations
290 papers · 9.6k indexed · 1 hit paper · h-index 50

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • Cancer Cells and Metastasis
    • Cancer Treatment and Pharmacology

Papers in

    • Breast Cancer Treatment Studies 53
    • Cancer Treatment and Pharmacology 46
    • HER2/EGFR in Cancer Research 29
    • Bone health and treatments 17
    • Colorectal Cancer Treatments and Studies 17

Tetsuya Taguchi

279 papers receiving 9.3k citations

Hit Papers

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy 2003 · 603 citations
6032003202620102018200400600

Peers

Tetsuya Taguchi
Comparison fields: 5 of 156
  • Cancer Research 2.2k
  • Oncology 3.1k
  • Clinical Biochemistry 392
  • Molecular Biology 3.8k
  • Pathology and Forensic Medicine 963
Replace Matías A. Ávila with:
Matías A. Ávila Spain
Gerald Höefler Austria
Hitoshi Yoshiji Japan
Atsushi Enomoto Japan
José M. López‐Novoa Spain
Marta Ruiz‐Ortega Spain
Alexander N. Orekhov Russia
Stuart J. Shankland United States
Kaikobad Irani United States
Anthony J. Valente United States
Tetsuya Taguchi relative to Matías A. Ávila Spain Matías A. Ávila's profile →
Citations per field
00.5×1.5×2.1×
Matías A. Ávila · 1×
Citations per year

Countries citing papers authored by Tetsuya Taguchi

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Taguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Taguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Taguchi more than expected).

Fields of papers citing papers by Tetsuya Taguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Taguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Taguchi. The network helps show where Tetsuya Taguchi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tetsuya Taguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsuya Taguchi Line = papers co-authored together Tetsuya Taguchi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 202111
3
[Experience of Fulvestrant for Hormone Receptor-Positive HER2-Negative Advanced and Metastatic Breast Cancer].
20181
4 20181
5 201518
6
[A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer].
20110
7 2009475
8 200816
9 200666
10 200682
11
20051
12 20058
13 200311
14 199865
15
[Comparative clinical study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres)].
19934
16
[Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
198912
17 19857
18
Increase in histidine decarboxylase activity in mouse skin after application of tumor promoters.
19834
19 19723
20
LETTERS TO THE EDITOR:SEX DIFFERENCE OF CADMIUM CONTENT IN SPOT URINES
19702

About Tetsuya Taguchi

Tetsuya Taguchi is a scholar working on Cancer Research, Oncology, Dermatology, Pathology and Forensic Medicine and Orthopedics and Sports Medicine, having authored 290 papers that have together received 9.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (53 papers), Cancer Treatment and Pharmacology (46 papers), HER2/EGFR in Cancer Research (29 papers), Estrogen and related hormone effects (28 papers), Breast Lesions and Carcinomas (23 papers), Breast Implant and Reconstruction (23 papers), Bone health and treatments (17 papers) and Colorectal Cancer Treatments and Studies (17 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.1k citations), Clinical Biochemistry (392 citations), Molecular Biology (3.8k citations) and Pathology and Forensic Medicine (963 citations). Tetsuya Taguchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shinzaburo Noguchi, Yasuhiro Tamaki, Yasuo Miyoshi, Seung Jin Kim, Kenzo Shimazu, Takeshi Matsumura, Yoshio Tanji, Eiichi Araki, Hiroyuki Motoshima and Tomonori Tanei. Their work appears in journals such as Breast Cancer, Cancer Letters, Breast Cancer Research and Treatment, International Journal of Cancer and Journal of Bone and Mineral Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026